HF
NVO

HRT Financial’s Novo Nordisk NVO Stock Holding History

HRT Financial’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-63,378
Closed -$3.22M – 4438
2025
Q4 		$3.22M Sell
63,378
-177,658
-74% -$9.08M 0.01% 1002
2025
Q3 		$13.4M Buy
241,036
+89,330
+59% +$5.23M 0.05% 299
2025
Q2 		$10.5M Buy
151,706
+92,142
+155% +$6.27M 0.05% 296
2025
Q1 		$4.14M Buy
59,564
+10,089
+20% +$833K 0.03% 517
2024
Q4 		$4.25M Buy
+49,475
New +$5.35M 0.02% 445
2022
Q2 		– Sell
-4,768
Closed -$264K – 3475
2022
Q1 		$264K Sell
4,768
-29,094
-86% -$1.49M ﹤0.01% 2318
2021
Q4 		$1.9M Sell
33,862
-37,076
-52% -$2.01M 0.01% 693
2021
Q3 		$3.4M Buy
+70,938
New +$3.43M 0.02% 463
2021
Q2 		– Sell
-71,390
Closed -$2.41M – 3313
2021
Q1 		$2.41M Buy
71,390
+47,208
+195% +$1.68M 0.02% 529
2020
Q4 		$844K Buy
+24,182
New +$836K 0.02% 762
2019
Q2 		– Sell
-11,900
Closed -$311K – 865
2019
Q1 		$311K Buy
+11,900
New +$292K 0.05% 285

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

HRT Financial's NVO Position: Q1 2026 in Review

HRT Financial sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 63,378 shares — an estimated $3.22M sold.

HRT Financial first reported a position in NVO in Q1 2019 and held it in 11 quarters. The position peaked at $13.4M in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • HRT Financial reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 63,378 Novo Nordisk shares in Q1 2026, an estimated $3.22M.
  • HRT Financial first reported a position in Novo Nordisk in Q1 2019 and held it in 11 quarters.
  • HRT Financial's Novo Nordisk position peaked at $13.4M in Q3 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.